We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 28, 2008

UNITED STATES OF AMERICA v. ALLERGAN, INC., ET AL

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 6, 2015

    AstraZeneca, Cephalon Pay $54M To End Medicaid Rebate Row

    AstraZeneca LP and Cephalon Inc. have agreed to pay $46.5 million and $7.5 million, respectively, to resolve claims brought by a whistleblower in a False Claims Act suit accusing the drugmakers of knowingly underpaying for rebates owed to the Medicaid Drug Rebate Program, federal prosecutors announced on Monday.

2 other articles on this case. View all »

Parties

To view the parties, register now.